Evidence map›Paper›PMID 33417491›Full record

ArticleJCO oncology practice2021

Mobile Applications: Breaking Barriers to Early Breast and Cervical Cancer Detection in Underserved Communities.

Carlos A Munoz-Zuluaga, José David Gallo-Pérez, Andrés Pérez-Bustos, Mavalynne Orozco-Urdaneta, Karen Druffel, Lida P Cordoba-Astudillo, Luis G Parra-Lara, Carolina Velez-Mejia, Farah El-Sharkawy, Katherin Zambrano-Vera and 3 more

Open access · greenAbstract read
In one paragraph

Article in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Carlos A Munoz-ZuluagaPartners for Cancer Care and Prevention, Baltimore, MD.ORCID 0000-0002-6125-3170
José David Gallo-PérezFundación para la Prevención y Tratamiento del Cáncer, Cali, Colombia.ORCID 0000-0003-2132-092X
Andrés Pérez-BustosFundación para la Prevención y Tratamiento del Cáncer, Cali, Colombia.ORCID 0000-0001-5934-2767
Mavalynne Orozco-UrdanetaPartners for Cancer Care and Prevention, Baltimore, MD.
Karen DruffelDruffel Consulting LLC, Elkridge, MD.ORCID 0000-0002-1330-0489
Lida P Cordoba-AstudilloFundación para la Prevención y Tratamiento del Cáncer, Cali, Colombia.ORCID 0000-0003-2875-5635
Luis G Parra-LaraFundación para la Prevención y Tratamiento del Cáncer, Cali, Colombia.ORCID 0000-0002-4877-1117
Carolina Velez-MejiaPartners for Cancer Care and Prevention, Baltimore, MD.ORCID 0000-0002-7969-2665
Farah El-SharkawyThe Institute for Cancer Care, Mercy Medical Center, Baltimore, MD.ORCID 0000-0001-6425-8404
Katherin Zambrano-VeraPartners for Cancer Care and Prevention, Baltimore, MD.ORCID 0000-0003-1310-4901
Raúl H ErazoFundación para la Prevención y Tratamiento del Cáncer, Cali, Colombia.
Mary C KingThe Institute for Cancer Care, Mercy Medical Center, Baltimore, MD.ORCID 0000-0002-3376-3827
Armando SardiPartners for Cancer Care and Prevention, Baltimore, MD.ORCID 0000-0003-4132-9489
Fundación Con Vida · COPartners for Cancer Care and Prevention · USMercy Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough potentially curable with early detection and timely treatment, breast cancer (BC) and cervical cancer (CC) remain leading causes of death for Colombian women. Lack of education, complicated administrative processes, and geographic limitations hinder early cancer detection. Today, technological tools permeate the society and could assess user risk, deliver customized information, and provide care coordination. We evaluated the effectiveness of a free mobile application (mApp) to reach women, understand misconceptions, identify users at risk for BC and/or CC, and coordinate screening tests in Cali, Colombia.

methodsThe mApp was developed and advertised in four healthcare facility waiting rooms. It used educational, evaluative, and risk factor questions followed by brief explanations to assess the population's knowledge, educate on BC and/or CC, and identify users in need of screening test(s). Women who required screening were navigated and enrolled in the national cancer program.

resultsFrom August 2017 to August 2019, 1,043 women downloaded the mApp. BC misconceptions included beliefs that BC can be prevented (87%), obesity does not increase the risk of BC (49%), and deodorant causes BC (17%). CC misconceptions included that pap smears should not be performed while sexually active (64%), vaginal pain is an early sign of CC (44%), and only women contract human papilloma virus (33%). Overall, 29% (303) were identified as at risk and needed a screening test, with 32% (98) successfully screened. DISCUSSION: mApps can identify women at risk for BC and/or CC, detect barriers to early cancer detection, and help coordinate screening test(s). This technology has widespread applications and may be useful in other underserved communities.

Indexed as

Uterine Cervical NeoplasmsColombiaEarly Detection of CancerFemaleHumansMass ScreeningVaginal Smears

Identifiers

PMID33417491
PMCPMC8258140
OpenAlexW3120305399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.